What is the cause of pleural effusion in yellow nail syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

The cause of pleural effusion in yellow nail syndrome is primarily lymphatic dysfunction, as evidenced by the most recent and highest quality study 1, which suggests that the syndrome is associated with impaired lymphatic drainage, leading to the accumulation of fluid in the pleural space.

Pathophysiology of Yellow Nail Syndrome

The pathophysiology of yellow nail syndrome involves increased capillary permeability and reduced lymphatic clearance, causing fluid to accumulate in the pleural space. This lymphatic dysfunction appears to be congenital in some cases but can also develop later in life, sometimes in association with other conditions such as malignancies, autoimmune diseases, or certain medications.

Characteristics of Pleural Effusion in Yellow Nail Syndrome

The pleural fluid in yellow nail syndrome is typically exudative with high protein content and predominantly lymphocytic, as reported in a systematic review of 112 studies 2. The appearance of the fluid is usually serous, but can also be milky or purulent. The pleural effusion is often bilateral and can be treated with pleurodesis or decortication/pleurectomy.

Treatment of Pleural Effusion in Yellow Nail Syndrome

Treatment of pleural effusion in yellow nail syndrome focuses on managing the effusion through thoracentesis or pleurodesis, rather than addressing the underlying lymphatic abnormality, which is generally not reversible. According to a review of management options 1, pleurodesis and decortication/pleurectomy are effective in treating symptomatic pleural effusions. Additionally, octreotide has been used to treat pleural effusions in yellow nail syndrome, with some success 3.

Key Points

  • Lymphatic dysfunction is the primary cause of pleural effusion in yellow nail syndrome
  • The pleural fluid is typically exudative with high protein content and predominantly lymphocytic
  • Treatment focuses on managing the effusion through thoracentesis or pleurodesis
  • Pleurodesis and decortication/pleurectomy are effective in treating symptomatic pleural effusions
  • Octreotide may be used to treat pleural effusions in yellow nail syndrome, but its effectiveness is variable.

References

Research

Yellow Nail Syndrome: A Case Presentation and a Review of Management Options.

South Dakota medicine : the journal of the South Dakota State Medical Association, 2021

Research

Yellow nail syndrome: treatment with octreotide.

The clinical respiratory journal, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.